Cartesian Therapeutics Inc. (NASDAQ: RNAC)
$17.96
+0.0400 ( +0.22% ) 144.4K
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Market Data
Open
$17.96
Previous close
$17.92
Volume
144.4K
Market cap
$384.62M
Day range
$17.88 - $18.79
52 week range
$11.67 - $41.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Oct 31, 2023 |
4 | Insider transactions | 1 | Sep 26, 2023 |
4 | Insider transactions | 1 | Sep 26, 2023 |
8-k | 8K-related | 12 | Sep 25, 2023 |
8-k | 8K-related | 12 | Sep 13, 2023 |
8-k | 8K-related | 15 | Aug 17, 2023 |
10-q | Quarterly Reports | 93 | Aug 17, 2023 |
nt | Quarterly Reports | 1 | Aug 14, 2023 |